Sarda Proteins Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sarda Proteins Ltd. on BSE

Search Inside the pdf :

02 Sep 2025

Board Meeting

Sarda Proteins Ltd - 519242 - Board Meeting Intimation for General Purpose

BSE India

Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/09/2025 ,inter alia, to consider and approve board report and other items.

pdf

Sarda Proteins Ltd.

14 Aug 2025

Result

Sarda Proteins Ltd - 519242 - Unaudited Financial Results For Quarter Ended June 30, 2025

BSE India

We submit the unaudited financial results for the quarter ended 30th June, 2025 pursuant to Regulation 33 of SEBI (LODR), 2015.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	10.96	0.00	0.00	-	-
Operating Profit Qtr	-0.49	-0.10	-0.08	-390.0%	-512.5%
Net Profit Qtr	-0.49	-0.11	-0.08	-345.5%	-512.5%
Earning Per Share Adjusted latest Qtr	-2.86	-0.65	-0.46	-340.0%	-521.7%

* Standalone data

Detailed Results

Sarda Proteins Ltd.

14 Aug 2025

Board Meeting

Sarda Proteins Ltd - 519242 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

We hereby submit outcome of Board Meeting held on August 14, 2025.

pdf

Sarda Proteins Ltd.

12 Aug 2025

Board Meeting

Sarda Proteins Ltd - 519242 - Board Meeting Intimation for Intimation Of Board Meeting For Approval …

BSE India

Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve the Standalone Unaudited Financial Results for the Quarter ended 30th June, 2025.

pdf

Sarda Proteins Ltd.

11 Aug 2025

Board Meeting

Sarda Proteins Ltd - 519242 - Board Meeting Outcome for General Purpose

BSE India

Intimation of Board Meeting to be held on Monday

pdf

Sarda Proteins Ltd.

06 Aug 2025

Board Meeting

Sarda Proteins Ltd - 519242 - Board Meeting Intimation for General Purpose.

BSE India

Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 ,inter alia, to consider and approve other businesses.

pdf

Sarda Proteins Ltd.

22 Jul 2025

Board Meeting

Sarda Proteins Ltd - 519242 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Sarda Proteins Limited is scheduled to be held on Friday, July 26, 2025, at 11:00 A.M. through Video Conferencing at the registered office of the Company, inter alia, to consider and approve the following matters: 1. To consider and approve the appointment of Ms. Rinkal Malviya as Woman Director (Executive Director) on the Board of the Company; 2. Proposal for change in the name of the Company from Sarda Proteins Limited to Onix Power Limited; 3. Proposal for shifting of the registered office of the Company. 4. To approve Notice of Extra-Ordinary General Meeting of the Company through Video Conferencing 5. To appoint Scrutinizer and E-voting Agency for the E-voting/ Remote e-voting process of the Company

pdf

Sarda Proteins Ltd.

08 Jul 2025

Company Update

Sarda Proteins Ltd - 519242 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find attached the certificate under Regulation 74(5) of SEBI (DP) Regulations for quarter ended June 30, 2025.

pdf

Sarda Proteins Ltd.

26 Jun 2025

SAST

Sarda Proteins Ltd - 519242 - Closure of Trading Window

BSE India

With reference to circular no LIST/COMP/01/2019-20 DATED 2ND APRIL 2019 and SEBI (Prohibition of Insider Trading) Regulation 2015 . Company''s intimation for closure of trading window for designated person from Tuesday 1st July 2025 till the 48 hours after announcement of unaudited financial of Quarter ended June 2025

pdf